by Columbia University Irving Medical Center After only a few days caring for critically ill COVID-19 patients at the start of the outbreak in New York City, Aakriti Gupta, MD, realized that this was much more than a respiratory disease. “I was on the front lines right from the beginning. I observed that patients were...
Dive Brief: India’s drug regulator has granted an emergency approval to the antibody drug itolizumab to treat the potentially deadly immune response, cytokine release syndrome, that appears to affect some patients hospitalized with acute respiratory distress related to COVID-19. The Drugs Controller General of India cleared the treatment for use after itolizumab, alongside standard of...
by BioMed Central Human papilloma viruses (HPVs) – a common group of viruses known to cause cervical cancers—may also have a causal role in prostate cancer, according to a literature review published in the open access journal Infectious Agents and Cancer, supporting the case for universal HPV vaccination. James Lawson and Wendy Glenn, at the...
MEDICAL COLLEGE OF GEORGIA AT AUGUSTA UNIVERSITY DRS. JACK YU AND BABAK BABAN view more CREDIT: PHIL JONES, SENIOR PHOTOGRAPHER, AUGUSTA UNIVERSITY Cannabidiol, or CBD, may help reduce the cytokine storm and excessive lung inflammation that is killing many patients with COVID-19, researchers say. While more work, including clinical trials to determine optimal dosage and...
Smoking habits trump asthma, obesity in risk factors for otherwise healthy population UNIVERSITY OF CALIFORNIA – SAN FRANCISCO As the number of young adults infected with the coronavirus surges throughout the nation, a new study by researchers at UCSF Benioff Children’s Hospitals indicates that youth may not shield people from serious disease. The study looked...
by Columbia University Irving Medical Center After only a few days caring for critically ill COVID-19 patients at the start of the outbreak in New York City, Aakriti Gupta, MD, realized that this was much more than a respiratory disease. “I was on the front lines right from the beginning. I observed that patients were...
Six months of coronavirus: the mysteries scientists are still racing to solve From immunity to the role of genetics, Nature looks at five pressing questions about COVID-19 that researchers are tackling. In late December 2019, reports emerged of a mysterious pneumonia in Wuhan, China, a city of 11 million people in the southeastern province of...
The second wave of COVID-19 is slowly emerging and countries have to be prepared. However, this is still a fairly new disease, which scientists are still trying to figure out. Now researchers at UCL found that COVID-19 can have neurological complications, which include delirium, brain inflammation, stroke and nerve damage. Scientists looked through the cases...
AMERICAN THORACIC SOCIETY IN A STUDY, BLACK RACE WAS ASSOCIATED WITH INCREASED COVID-19 INFECTION RISK. view more CREDIT: ATS July 08, 2020 – Results of an analysis published in the Annals of the American Thoracic Society found that Black individuals were twice as likely as White individuals to test positive for COVID-19. The average age...
Asthma does not seem to increase the risk of a person contracting COVID-19 or influence its severity, according to new research. Researchers say further study is needed but those with the chronic respiratory disease don’t appear to be at a higher risk of getting extremely ill or dying from coronavirus. “Older age and conditions such...
